HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation, risk stratification, and management of pulmonary hypertension in patients with congenital heart disease.

Abstract
Surgical outcomes for patients with congenital heart disease have improved dramatically over the past few decades due, in part, to improvements in preoperative and postoperative management, cardiopulmonary bypass and intraoperative technique, and the development of pediatric cardiology as a subspecialty. Patients with pulmonary hypertension, however, remain a particularly challenging subgroup worldwide. Determination of operability and, when reasonable, timing of surgery, remains at times difficult. An overview of the evaluation process for this patient population is presented along with a review of evidence for risk stratification and a generalized account of the current state of medical therapy.
AuthorsJeffrey A Feinstein
JournalSeminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual (Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu) Pg. 106-11 ( 2009) ISSN: 1092-9126 [Print] United States
PMID19349023 (Publication Type: Journal Article, Review)
Topics
  • Cardiac Surgical Procedures (methods)
  • Heart Defects, Congenital (complications, surgery)
  • Humans
  • Hypertension, Pulmonary (complications, surgery)
  • Infant
  • Infant, Newborn
  • Patient Selection
  • Risk Assessment
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: